Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Receivables (2016 - 2026)

Healthcare Services has reported Receivables over the past 18 years, most recently at $50.4 million for Q1 2026.

  • Quarterly Receivables fell 85.08% to $50.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $50.4 million through Mar 2026, down 85.08% year-over-year, with the annual reading at $281.3 million for FY2025, 14.99% down from the prior year.
  • Receivables was $50.4 million for Q1 2026 at Healthcare Services, down from $281.3 million in the prior quarter.
  • Over five years, Receivables peaked at $407.1 million in Q1 2024 and troughed at $50.4 million in Q3 2025.
  • The 5-year median for Receivables is $344.8 million (2022), against an average of $314.2 million.
  • Biggest five-year swings in Receivables: rose 26.24% in 2022 and later crashed 87.6% in 2025.
  • Tracing HCSG's Receivables over 5 years: stood at $344.8 million in 2022, then grew by 0.01% to $344.9 million in 2023, then decreased by 4.05% to $330.9 million in 2024, then dropped by 14.99% to $281.3 million in 2025, then tumbled by 82.08% to $50.4 million in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $50.4 million, $281.3 million, and $50.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.